JARDIANZ 10 mg – 30 Coated Tablets for Diabetes Treatment

Description

Active Ingredient: Each tablet contains 10 mg of Empagliflozin.

Indications:
JARDIANZ is indicated for the treatment of uncontrolled type 2 diabetes mellitus as an adjunct to diet and exercise. It may be used as monotherapy when metformin is not suitable due to intolerance, or in combination with other diabetes medications to enhance glycemic control.

Moreover, it contributes to reducing the risk of cardiovascular mortality in adults with established cardiovascular disease and type 2 diabetes, making it a significant option for comprehensive diabetes management.

Directions for Use: Always follow your healthcare professional’s guidance regarding the use of this medication. Consult your doctor for personalized advice and before starting any new treatment.

Contraindications:
This medication should not be used in patients with hypersensitivity to Empagliflozin. It is contraindicated in individuals with end-stage renal disease or those on dialysis. Pregnant and breastfeeding women should avoid this medication.

Note: JARDIANZ tablets contain lactose. Patients with hereditary galactose intolerance, lactase deficiency, or glucose-galactose malabsorption must not take this product.

Composition

Active Ingredient	Strength / Concentration
EMPAGLIFLOZINA	10 mg.

Medical Note

Empagliflozin is an antidiabetic medication classified as an SGLT2 inhibitor. It works by preventing glucose reabsorption in the kidneys, thus promoting its excretion through urine. Always consult a healthcare professional before use.

Testimonial

“Roberto, 38, from Chicago, said the order process was straightforward, and he appreciated receiving complete documentation with clear tracking details. The transparency made him feel confident about his purchase.”